ENTRY       5732              CDS       T01001
NAME        PTGER2, EP2
DEFINITION  (RefSeq) prostaglandin E receptor 2
ORTHOLOGY   K04259  prostaglandin E receptor 2
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa04024  cAMP signaling pathway
            hsa04080  Neuroactive ligand-receptor interaction
            hsa04750  Inflammatory mediator regulation of TRP channels
            hsa04924  Renin secretion
            hsa05200  Pathways in cancer
DRUG_TARGET Butaprost: D03187
            Dinoprostone (DG00448): D00079 D03269
            Evatanepag (DG01894): D09613 D09614
            Misoprostol: D00419
            Rioprostil: D05732
            Sulprostone: D02725
            Taprenepag (DG01895): D09968 D09969
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Environmental Information Processing
              Signal transduction
               04024 cAMP signaling pathway
                5732 (PTGER2)
              Signaling molecules and interaction
               04080 Neuroactive ligand-receptor interaction
                5732 (PTGER2)
             Organismal Systems
              Endocrine system
               04924 Renin secretion
                5732 (PTGER2)
              Sensory system
               04750 Inflammatory mediator regulation of TRP channels
                5732 (PTGER2)
             Human Diseases
              Cancers
               05200 Pathways in cancer
                5732 (PTGER2)
            G protein-coupled receptors [BR:hsa04030]
             Class A. Rhodopsin family
              Lipid
               Prostaglandin
                5732 (PTGER2)
POSITION    14q22.1
MOTIF       Pfam: 7tm_1 7TM_GPCR_Srx 7TM_GPCR_Srsx Srg DUF412
DBLINKS     NCBI-GeneID: 5732
            NCBI-ProteinID: NP_000947
            OMIM: 176804
            HGNC: 9594
            Ensembl: ENSG00000125384
            Vega: OTTHUMG00000140300
            Pharos: P43116(Tclin)
            UniProt: P43116
AASEQ       358
            MGNASNDSQSEDCETRQWLPPGESPAISSVMFSAGVLGNLIALALLARRWRGDVGCSAGR
            RSSLSLFHVLVTELVFTDLLGTCLISPVVLASYARNQTLVALAPESRACTYFAFAMTFFS
            LATMLMLFAMALERYLSIGHPYFYQRRVSRSGGLAVLPVIYAVSLLFCSLPLLDYGQYVQ
            YCPGTWCFIRHGRTAYLQLYATLLLLLIVSVLACNFSVILNLIRMHRRSRRSRCGPSLGS
            GRGGPGARRRGERVSMAEETDHLILLAIMTITFAVCSLPFTIFAYMNETSSRKEKWDLQA
            LRFLSINSIIDPWVFAILRPPVLRLMRSVLCCRISLRTQDATQTSCSTQSDASKQADL
NTSEQ       1077
            atgggcaatgcctccaatgactcccagtctgaggactgcgagacgcgacagtggcttccc
            ccaggcgaaagcccagccatcagctccgtcatgttctcggccggggtgctggggaacctc
            atagcactggcgctgctggcgcgccgctggcggggggacgtggggtgcagcgccggccgc
            aggagctccctctccttgttccacgtgctggtgaccgagctggtgttcaccgacctgctc
            gggacctgcctcatcagcccagtggtactggcttcgtacgcgcggaaccagaccctggtg
            gcactggcgcccgagagccgcgcgtgcacctacttcgctttcgccatgaccttcttcagc
            ctggccacgatgctcatgctcttcgccatggccctggagcgctacctctcgatcgggcac
            ccctacttctaccagcgccgcgtctcgcgctccgggggcctggccgtgctgcctgtcatc
            tatgcagtctccctgctcttctgctcgctgccgctgctggactatgggcagtacgtccag
            tactgccccgggacctggtgcttcatccggcacgggcggaccgcttacctgcagctgtac
            gccaccctgctgctgcttctcattgtctcggtgctcgcctgcaacttcagtgtcattctc
            aacctcatccgcatgcaccgccgaagccggagaagccgctgcggaccttccctgggcagt
            ggccggggcggccccggggcccgcaggagaggggaaagggtgtccatggcggaggagacg
            gaccacctcattctcctggctatcatgaccatcaccttcgccgtctgctccttgcctttc
            acgatttttgcatatatgaatgaaacctcttcccgaaaggaaaaatgggacctccaagct
            cttaggtttttatcaattaattcaataattgacccttgggtctttgccatccttaggcct
            cctgttctgagactaatgcgttcagtcctctgttgtcggatttcattaagaacacaagat
            gcaacacaaacttcctgttctacacagtcagatgccagtaaacaggctgacctttga
///
